Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B

References

• Ahmed M, Ramadan W, Rambhu D, Shakeel F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie 63:806–11
   PubMed Web of Science ®Google Scholar
• Attwood D, Mallon D, Taylor CJ. (1992). Phase studies on oil in water microemulsions. Int J Pharm 8:R5–8
   Web of Science ®Google Scholar
• Azeem A, Rizwan M, Ahmad FJ, et al. (2009). Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 10:69–76
   PubMed Web of Science ®Google Scholar
• Chang SC, Lin SJ, Chen TW, Lin YT. (2012). A biocide-free mineral oil nanoemulsion exhibiting strong bactericidal activity against Mycobacterium immunogenum and Pseudomonas aeruginosa. Int Biodeter Biodegr 70:66–73
   Web of Science ®Google Scholar
• Chen H, Chang X, Du D, et al. (2006). Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 110:296–306
   PubMed Web of Science ®Google Scholar
• Espuelas MS, Legrand P, Irache JM, et al. (1997). Poly(ɛ-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity. Int J Pharm 158:19–27
   Web of Science ®Google Scholar
• Fukui H, Koike T, Nakagawa T, et al. (2003a). Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations. Int J Pharm 267:101–12
   PubMed Web of Science ®Google Scholar
• Fukui H, Koike T, Saheki A, et al. (2003b). Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS). Int J Pharm 263:51–60
   PubMed Web of Science ®Google Scholar
• Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, et al. (2005). The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 291:79–86
   PubMed Web of Science ®Google Scholar
• Hussain A, Haque MW, Singh SK, Ahmed FJ. (2015). Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2015.1124473
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Nazish I, Ahmed FJ. (2013). Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 40:527–41
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Singh SK, et al. (2014a). Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B. Drug Dev Ind Pharm 41:780–90
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Singh SK, et al. (2014b). Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv 23:652–67
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Ramzan M, et al. (2016). Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Drug Deliv . [Epub ahead of print]. DOI: 10.3109/10717544.2014.976891
   PubMed Web of Science ®Google Scholar
• Hussain A, Singh SK. (2016). Evidences for anti-mycobacterium activities of lipids and surfactants. World J Microbiol Biotechnol 32:7. doi: 10.1007/s11274-015-1965-4
   PubMed Web of Science ®Google Scholar
• Jain SK, Gupta Y, Jain A, Rai K. (2008). Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 15:141–7
   PubMed Web of Science ®Google Scholar
• Joe MM, Bradeeba K, Parthasarathi R, et al. (2012). Development of surfactin-based nanoemulsion formulation from selected cooking oils: evaluation for antimicrobial activity against selected food associated microorganisms. J Taiwan Inst Chem Eng 43:172–80
   Web of Science ®Google Scholar
• Kadimi US, Balasubramanian DR, Ganni UR, et al. (2007). In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide-mediated process. Nanomedicine 3:273–80
   PubMed Web of Science ®Google Scholar
• Kalhapure RS, Suleman N, Mocktar C, et al. (2015). Nanoengineered drug delivery systems for enhancing antibiotic therapy. J Pharm Sci 104:872–905
   PubMed Web of Science ®Google Scholar
• Kleinberg M. (2006). What is the current and future status of conventional amphotericin B? Int J Antimicrob Agents 27S:S12–6
   Web of Science ®Google Scholar
• Nahar M, Mishra D, Dubey V, Jain NK. (2008). Development, characterization and toxicity evaluation of amphotericin B-loaded nanogelatin nanoparticles. Nanomedicine 4:252–61
   PubMed Web of Science ®Google Scholar
• Ouellette M, Drummelsmith J, Papadopoulou B. (2004). Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat 7:257–66
   PubMed Web of Science ®Google Scholar
• Sarker SD, Nahar L, Kumarasamy Y. (2007). Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 42:321–4
   PubMed Web of Science ®Google Scholar
• Shafaat K, Kumar B, Das SK, et al. (2013). Novel nanoemulsion as vehicle for transdermal delivery of clozepine in vitro and in vivo studies. Int J Pharm Pharm Sci 5:126–34
   Google Scholar
• Singh N, Verma SM, Singh SK, Verma PR. (2015). Evidence for bactericidal activities of lipidic nanoemulsions against Pseudomonas aeroginosa. Antonie Van Leeuwenhoek 107:1555–68
   PubMed Web of Science ®Google Scholar
• Teichmann A, Heuschkel S, Jacobi U, et al. (2007). Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm 67:699–706
   PubMed Web of Science ®Google Scholar
• Utreja P, Jain S, Tiwar AK. (2011). Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation. Drug Deliv 18:367–76
   PubMed Web of Science ®Google Scholar
• Wissing SA, Lippacher A, Müller RH. (2001). Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 52:313–23
   PubMed Web of Science ®Google Scholar
• Wong-Beringer A, Jacobs RA, Guglielmo BJ. (1998). Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis 27:603–18
   PubMed Web of Science ®Google Scholar